Try our Advanced Search for more refined results
Life Sciences - September, 2009
192 articles
- Medmarc Ordered To Cover St. Jude Settlements
- Auxilium Wins Bid To Toss Most Of FLSA, Bias Suit
- Forest Settles Suit Over Celexa, Lexapro Kickbacks
- DC Circ. Backs Military's Mandated Anthrax Vaccine
- Taro Sues Sun Over Withholding Troubles At Unit
- Jury Finds Ex-Intermune CEO Guilty Of Wire Fraud
- ACCC Clears $68B Pfizer, Wyeth Deal With Conditions
- Govs. Call For Strong Biologic Data Protection
- Boston Scientific To Pay Cordis $716M In Stent War
- Elan Subpoenaed By SEC Over Drug Disclosures
- Glaxo Yanks Cervarix Batch After UK Death
- Lilly To Pay Conn. $25M Over Zyprexa Marketing
- Fen-Phen Plaintiffs Firm Hits Back In Insurance Spat
- NJ Supreme Court Upholds $4.5M Vioxx Verdict
- Kroes Vows More EC Antitrust Reviews For Drug Cos.
- Elan Files $600M Notes Offering, $850M Tender Offer
- Albion Drops Supplement Patent Suit Against Seton
- Insurer Fends Off Genzyme's Bid For Coverage
- China's Impending Disclosure Of Origin Law
- 1st Circ. Revives Consumer AWP Claims Against J&J
- Sandoz Admits To Infringing Ortho Tri-Cyclen Patent
- Antitrust Suit Against Big Pharma, Distributors Tossed
- Direct Purchasers Want Market Docs In Wellbutrin MDL
- Neurontin Plaintiffs Make Bid For Class Certification
- Catheter Antitrust Claims Against CR Bard Nixed
- Win For Health Care Boss Affirmed In Insurance Spat
- CVS, Wal-Mart Seek Toss Of Drug Overcharge Action
- Abbott To Buy Solvay's Pharma Unit For $6.6B Cash
- Albion Sues TriGen Over Iron Supplement Patent
- Eisai Urges Court To Toss Apotex Suit Over Aricept
- ReNu Economic Loss Plaintiffs Lose Bid For 2 Classes
- Genesis Biosystems Sues Over Liposuction Patent
- FDA Vet Joins Nixon Peabody From Latham & Watkins
- Covidien Snags Brain Monitor Co. Aspect For $210M
- Australian Towns Get OK To Pursue Lehman Claims
- Cordis Appeals $22M Verdict In Stent Patent Suit
- Janssen Alzheimer's Patent Not Valid: Fed. Circ.
- Sanofi Wins Dismissal Of Securities Action
- FDA Admits Knee Device Approval Was Compromised
- Deal Pros Brace For More Antitrust 2nd Looks
- Merck Diabetes Drugs Include Pancreatitis Risk: FDA
- Novartis, 2 Generics Drop Lotrel Patent Lawsuits
- Fed. Circ. Upholds AstraZeneca's Seroquel Patent Win
- Judge Favors Bayer In Livestock Drug Patent Spat
- Patent Reform And The Future Of Pharma Patents
- Stock Promoter Dropped From CellCyte Fraud Suit
- Guidance Loses Bid To Alter Damages Before Trial
- Cordis Wins 2nd Dismissal Of Stent Patent Suit
- Abbott Pays $27M To End C&D Pregnancy Test Feud
- MDL Judges Can't Meddle In Past Orders: 3rd Circ.
- Patient Groups Urge Congress To Support Biosimilars
- Senate Panel Plans Looser Rules On Pay-For-Delay
- Ex-McDermott, Dorsey Attys Face Insider Trading Trial
- Judge Quashes Teva Bid To Introduce Generic Evista
- FDA Taps IOM To Study Premarket Approval Process
- Wyeth Loses Bid For TRO On Generic Zosyn
- Supporting Patentability With Commercial Success
- AstraZeneca Loses $12.9M AWP Appeal
- Bristol-Myers Settles Wholesale Drug Price Suit
- Wyeth Sues FDA To Block Generic Zosyn
- Gilbert Lures Insurance Lawyer Back From Dickstein
- Pimco: Another Guidepost For Class Certification
- Mannatech, Rival Settle Supplement Patent Spat
- Wyeth, Cordis Sue Abbott, Boston Sci Over Stent
- Baucus Tweaks Bill To Make Health Care Cheaper
- Fed. Circ. Says Aneurysm Patents Weren't Infringed
- Wholesalers Drop Merck Antitrust Suit Over Singulair
- Insider Trading Rap Sticks To NBTY Lawyer
- Merck, Schering Win Initial OK For $42M Vytorin Deal
- AstraZeneca Seeks Ruling in Crestor Patent MDL
- Life Tech Sues Biosearch Tech Over Assay Patents
- Guidant Found Not Liable In Shocking Pacemaker Suit
- AstraZeneca Units Dropped From Pain Pump Suits
- PPA MDL Plaintiffs' Lawyers Divvy Up $15.5M
- Buyers Bullish On Future Of M&A: Survey
- Biogen Idec Launches $356M Tender Offer For Facet
- TriCor Purchasers Seek To Finalize $65M Settlement
- Teva Appeals Singulair Patent Suit To Fed. Circ.
- Sepracor Investor Sues Over Dainippon Takeover
- Acacia, AGFA Drop Imaging Patent Suit
- Pfizer Accuses Expert Of Tainting Doctor Testimony
- Levaquin MDL Continues To Grow
- Apotex Appeals Redaction Ruling In Wyeth Patent Suit
- Conrad O'Brien Snags Ex-Synthes Patent Chief
- Former Pfizer Counsel Joins Nixon Peabody
- Philadelphia At Center Of State Yaz Litigation
- Antitrust Claims Shorn In Eyelash Product Patent Suit
- Brown Rudnick Bags Cooley Patent Team
- FDA Says Allergan Misleads Public On Eyelash Drug
- J&J Closes $885M Alzheimer's Drug Deal With Elan
- Ex-Lehman Broker Gets Probation In Insider Case
- Ariz., Bristol-Myers Squibb Settle AWP Drug Case
- IPO Market Buzz Prompts Preparation For Better Days
- Tafas V. Doll: Repercussions Of En Banc
- FDA Warns Bayer About Testing At German Plant
- Bayer Asks Court To Scrap MDL On Aspirin Marketing
- DLA Piper Adds Patterson Belknap Chemist, Attorney
- Fed. Circ. Tosses Ruling For Mayo Nixing Test Patents
- Investor Class Action Strikes At CardioNet's Heart
- Monsanto Retirees Want Class OK'd In ERISA Fight
- FDA Insists On Box Warning For Promethazine
- Huntsman, Economy Hasten Push For Closing Clarity
- Reps Join Push To Reopen CVS Caremark Probe
- Micron Seeks To Trim Claims In Drug Contract Spat
- Sandoz, Dr. Reddy's Sued Over Allegra Patent
- BU Must Hand Over Docs In Paxil Birth Defect Case
- Biovail Unit Enters Guilty Plea In Kickbacks Case
- Fed. Circ. Keeps Ban On Roche's US Mircera Sales
- Schering-Plough, Merck Seek To Toss Vytorin Suit
- Feds Fight To Keep Protonix Bundling Suit Alive
- Plaintiff Seeks FDA Info In Apotex Preemption Case
- Teva Agrees To License Shire Patent For Carbatrol
- Arguing Preemption In The 11th Circ. Post-Levine
- Elan Says It Has Cured Tysabri Contract Breach
- Warner Chilcott Sues Lupin Over Femcon, Loestrin IP
- Court Braces For More GSK, P&G Denture Cream Suits
- 9th Circ. Backs Ban On Tobacco Sales In SF Pharmas
- Jury Lets Nova Off Hook In Trade Secrets Spat
- Medtronic Catheter, Tube Combo Prompts Recall
- Interference Claim Nixed In Guidance Antitrust Suit
- Upsher-Smith, Others Exit Namenda Patent Case
- Deal Contract Language Revamped After Meltdown
- Teva's Suit Over Aricept Infringement Tossed
- Fosamax Judge Calls A Mistrial In Bellwether Case
- Smiths Medical Recalls Tracheal Tubes
- Ex-Howrey IP Partner Joins Dechert
- CA On Verge Of Finalizing Web Browser Patent Win
- Derivative Suit Filed In Wake Of Record Pfizer Payout
- Fund Relaunches Trasylol Class Action Against Bayer
- Abbott Tries To Nix Amended HIV Drug Price Suits
- Medtronic Warns About Faulty Defibrillator Batteries
- Barroway Topaz Opens San Francisco Office
- Guidant Cleared In Death Of Toddler With Pacemaker
- Key Wins For Baxter Nixed In Dialysis Patent Suit
- Fed. Circ. Hands Sanofi Victory In Eloxatin Spat
- Abbott Snaps Up Evalve In $410M Deal
- Dentsply, Tulsa Fail To Nix Some Claims In Suit
- Lupin, Novartis Drop Patent Dispute Over Lotrel
- Jury Says Axiom Infringed Electrotherapy Patent
- Arthrex Wins Judgment In ACL Surgery Patent Suit
- Fosamax Jurors Get Daylong 'Cooling-Off Period'
- 'Viagra Missile' Shot Down For Violating Pfizer's IP
- Merck Loses Bid To Toss 24 Fosamax Cases
- Protests Over $2.6B Sepracor Deal Begin To Roll In
- Baxter Escapes Wrongful Death Suit In Heparin MDL
- TriCor Indirect Purchasers' Attys Seek $22M In Fees
- SEC Says CellCyte Swindled Stem Cell Investors
- Medline Seeks Injunction In 3M Hand Scrub Battle
- Burns & Levinson Snaps Up K&L Gates IP Experts
- FDA Pulls Unauthorized OTC Anti-Microbial Products
- AstraZeneca Aims To Cut NY, NJ Plaintiffs From MDL
- SC Says Lilly, Doctors Made Golf Bets Over Zyprexa
- Millennium, J&J Unit Take US Side In Velcade IP Suit
- Sanctions Sought In Discovery Spat V. Mutual Pharma
- Cadence Taps Latham For $100M Offering
- EPA Seeks OK For Alcatel, Pfizer Cleanup Cost Deal
- Dental Supply Cos. Seek Sanctions In Contract Spat
- Elan-J&J Deal Breaches Biogen Tysabri Deal: Court
- Pittsburgh Univ. Scientist Accused Of Cancer Fraud
- US Asks CIT To Dismiss Thermal Cycler Duties Action
- Fed Circ. Says Lonza Infringed Martek Patents
- Novartis Execs Best Derivative Shareholder Claims
- 1st Circ. Nixes Pharmacies' Appeal Of AWP Deals
- Purdue Appeals Par's Defeat Of Ultram Patents
- 6th Circ. Sides With Novartis In Retaliatory Firing Case
- Ex-Tyco Affiliate Covidien Inks Deals To Sell 2 Units
- Miss. Wants Teva Fraud Suit Back In State Court
- Dainippon To Acquire Sepracor For $2.6B
- Minn. High Court OKs Prempro Cases Against Wyeth
- Pharmacies Appeal AWP Class Action Settlement
- Thermo Fisher Scientific Snags Brahms For $470M
- Endo Looks To Join Genzyme-Impax Renagel Battle
- Skadden Health Group Nabs King & Spalding Partner
- Amgen, Roche OK Temporary Mircera Import Ban
- ICU Seeks Details On RyMed Expert In IV Valve Spat
- 2nd Circ. Deep-Sixes ERISA Lawsuit Against J&J
- Navinta Appeals Infringement Ruling Over Naropin
- LEO Pharma To Purchase Peplin For $287.5M
- Bronx Manager Hits Rite Aid With OT Class Action
- FDA Approves KV's Drug Manufacturing Plan
- Vioxx Litigation Group Keeps Up Protest Over Fee Cap
- Vytorin Securities Suits Survive Dismissal Bids
- Pfizer Finalizes $2.3B Bextra Off-Label Marketing Deal
- Schering-Plough ERISA Suit Tossed
- AMA Calls Myriad's Gene Patents Unconstitutional
- Abrika Looks To Protect Documents In Wellbutrin Case
- Apotex Slapped With Injunction In Fortical Patent Suit
- Ven-A-Care, Abbott Face Off In Drug Prices Suit
- Cephalon Tries To Quash FTC Pay-For-Delay Suit
- Judge Slams Complaint Over Walgreens Drug Rate
- Merck, Patient Seek Separate JMOL In Fosamax Trial
- No $473M Tax Refund For Schering-Plough: Judge